IHE vs XLV: holdings overlap, shared companies and scores
As of September 11, 2026, IHE and XLV overlap 36.4% by weight. iShares U.S. Pharmaceuticals ETF (IHE): U.S. pharmaceutical manufacturers. State Street Health Care Select Sector SPDR ETF (XLV): U.S. healthcare sector.
Updated September 11, 2026
How much do IHE and XLV overlap?
As of September 11, 2026, IHE and XLV overlap 36.4% by weight.
67% of IHE is already inside XLV.
37% of XLV is already inside IHE.
IHE holds 56 companies and XLV holds 59; 7 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score IHE and XLV?
As of September 11, 2026, ETF Copilot scores IHE 6.4 out of 10 and XLV 5.5 out of 10.
They differ most on Quality: IHE 7.1 and XLV 4.7.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | IHE | XLV |
|---|---|---|
| Growth | 8.5 | 7.9 |
| Valuation | 4.1 | 3.5 |
| Risk | 6.6 | 7.4 |
| Quality | 7.1 | 4.7 |
| Return | 5.1 | 3.6 |
XLV is the cheaper of the two at 0.08% a year
As of September 11, 2026, IHE charges 0.37% a year, yields 1.83% and holds $1.7B in assets across 56 positions.
As of September 11, 2026, XLV charges 0.08% a year, yields 1.80% and holds $43.4B in assets across 59 positions.
| Measure | IHE | XLV |
|---|---|---|
| Expense ratio | 0.37% | 0.08% |
| Dividend yield | 1.83% | 1.80% |
| Assets under management | $1.7B | $43.4B |
| Holdings | 56 | 59 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Where IHE and XLV trade against their own history
IHE trades at 27.3 times earnings, against its own median of 22.5, and is more expensive than 89% of its own 114 monthly readings since 2017.
XLV trades at 30.3 times earnings, against its own median of 24.7, and is more expensive than 87% of its own 114 monthly readings since 2017.
What moved IHE and XLV this week
IHE fell 4.1% in the week to September 11, 2026. The holdings that moved it most were Johnson & Johnson (−4.6%), Eli Lilly (−3.8%) and Royalty Pharma (−8.2%); Axsome Therapeutics (+6.0%) pushed the other way.
XLV fell 4.6% in the week to September 11, 2026. The holdings that moved it most were Eli Lilly (−3.8%), Amgen (−15.0%) and Johnson & Johnson (−4.6%); HCA Healthcare (+4.3%) pushed the other way.
What do IHE and XLV each hold?
78% of IHE is its ten largest holdings.
What's inside XLV: AI 0%.
61% of XLV is its ten largest holdings.
Compare with similar funds
Cite this
ETF Copilot, “IHE vs XLV holdings overlap and scores”, as of September 11, 2026.
https://etf-copilot.com/compare/ihe-vs-xlv
Register free to unlock IHE vs XLV prices and holdings on ETF Copilot.
Register free →